Late-line colorectal cancer

By third line, metastatic colorectal cancer gives a median of five to six months in routine practice.1

Around a quarter of patients are already at that stage the day they are diagnosed.2

5–61
months, median survival by third line in routine practice
1 in 42
patients are already at that stage the day they are diagnosed

Late-line colorectal cancer has been a holding pattern for a decade. We are working to end it.

Please note: Veribrix Pharma operates in a stealth capacity.

We read what comes in and answer where we can. Your details are kept to reply to you and for nothing else. Privacy policy.